prabhakaran
☆    

India,
2013-05-12 12:46
(4776 d 08:05 ago)

Posting: # 10574
Views: 3,175
 

 accepting analytical batch [Regulatives / Guidelines]

i want to know the acceptance and rejection criteria for an analytical batch..all the regulatory authorities from different countries will have different criteria but i want to know the common criteria which is acceptable by all.???
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2013-05-12 15:59
(4776 d 04:51 ago)

@ prabhakaran
Posting: # 10575
Views: 2,674
 

 Intersection and union sets

Hi Prabhakaran,

please see the Forum’s Policy!

❝ i want to know the acceptance and rejection criteria for an analytical batch..


Do you see the link Guidelines above? Please do your own homework first.

❝ all the regulatory authorities from different countries will have different criteria


On the contrary I would say their criteria are remarkably similar.

❝ but i want to know the common criteria which is acceptable by all.???


What do you expect from fulfilling just the intersection?

[image]


You will not be fully compliant with any of them. So what’s your point?
If you want to submit your study to three authorities you have to be compliant with all of them.

[image]



Example: For the FDA you have to document recovery and for the EMA carry-over. If you want to use a method acceptable for both you should show recovery and carry-over in the validation. Maybe you leave out the irrelevant sections in the submission in order not to confuse check-list assessors. ;-) Furthermore, ISR is not mentioned in FDA’s guidance – nevertheless, I bet that they expect you to show it.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
AngusMcLean
★★  

USA,
2013-05-16 18:27
(4772 d 02:23 ago)

@ Helmut
Posting: # 10593
Views: 2,513
 

 Intersection and union sets

Helmut: You are correct about Incurred Sample Repeats: the FDA definitely expects that they will be done. I know this from my own consulting activities.

Angus
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2013-05-17 17:36
(4771 d 03:15 ago)

@ AngusMcLean
Posting: # 10599
Views: 2,483
 

 FDA guidance revision

Hi Angus,

FDA announced that they will revise the bioanalytical method validation guidance this year. Are there any news?

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
121 visitors (0 registered, 121 guests [including 22 identified bots]).
Forum time: 20:51 CEST (Europe/Vienna)

The epistemological value of probability theory is based on the fact
that chance phenomena, considered collectively and on a grand scale,
create non-random regularity.    Andrey Kolmogorov

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5